Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2014 Jan 13;2014(1):CD002115.
doi: 10.1002/14651858.CD002115.pub5.

Management of faecal incontinence and constipation in adults with central neurological diseases

Maureen Coggrave  1 , Christine Norton, June D Cody
Affiliations
Meta-Analysis

Management of faecal incontinence and constipation in adults with central neurological diseases

Maureen Coggrave et al. Cochrane Database Syst Rev. .

Update in

Abstract

Background: People with central neurological disease or injury have a much higher risk of both faecal incontinence and constipation than the general population. There is often a fine line between the two symptoms, with any management intended to ameliorate one risking precipitating the other. Bowel problems are observed to be the cause of much anxiety and may reduce quality of life in these people. Current bowel management is largely empirical, with a limited research base. This is an update of a Cochrane review first published in 2001 and subsequently updated in 2003 and 2006. The review is relevant to individuals with any disease directly and chronically affecting the central nervous system (post-traumatic, degenerative, ischaemic or neoplastic), such as multiple sclerosis, spinal cord injury, cerebrovascular disease, Parkinson's disease and Alzheimer's disease.

Objectives: To determine the effects of management strategies for faecal incontinence and constipation in people with a neurological disease or injury affecting the central nervous system.

Search methods: We searched the Cochrane Incontinence Group Trials Register (searched 8 June 2012), which includes searches of the Cochrane Central Register of Controlled Trials (CENTRAL), MEDLINE and MEDLINE In-Process as well as handsearching of journals and conference proceedings; and all reference lists of relevant articles.

Selection criteria: Randomised and quasi-randomised trials evaluating any type of conservative or surgical intervention for the management of faecal incontinence and constipation in people with central neurological disease or injury were selected. Specific therapies for the treatment of neurological diseases that indirectly affect bowel dysfunction were also considered.

Data collection and analysis: At least two review authors independently assessed the risk of bias of eligible trials and independently extracted data from the included trials using a range of pre-specified outcome measures.

Main results: Twenty trials involving 902 people were included. Oral medications There was evidence from individual small trials that people with Parkinson's disease had a statistically significant improvement in the number of bowel motions or successful bowel care routines per week when fibre (psyllium) (mean difference (MD) -2.2 bowel motions, 95% confidence interval (CI) -3.3 to -1.4) or oral laxative (isosmotic macrogol electrolyte solution) (MD 2.9 bowel motions per week, 95% CI 1.48 to 4.32) are used compared with placebo. One trial in people with spinal cord injury showed statistically significant improvement in total bowel care time comparing intramuscular neostigmine-glycopyrrolate (anticholinesterase plus an anticholinergic drug) with placebo (MD 23.3 minutes, 95% CI 4.68 to 41.92).Five studies reported the use of cisapride and tegaserod in people with spinal cord injuries or Parkinson's disease. These drugs have since been withdrawn from the market due to adverse effects; as they are no longer available they have been removed from this review. Rectal stimulants One small trial in people with spinal cord injuries compared two bisacodyl suppositories, one polyethylene glycol-based (PGB) and one hydrogenated vegetable oil-based (HVB). The trial found that the PGB bisacodyl suppository significantly reduced the mean defaecation period (PGB 20 minutes versus HVB 36 minutes, P < 0.03) and mean total time for bowel care (PGB 43 minutes versus HVB 74.5 minutes, P < 0.01) compared with the HVB bisacodyl suppository.Physical interventions There was evidence from one small trial with 31 participants that abdominal massage statistically improved the number of bowel motions in people who had a stroke compared with no massage (MD 1.7 bowel motions per week, 95% CI 2.22 to 1.18). A small feasibility trial including 30 individuals with multiple sclerosis also found evidence to support the use of abdominal massage. Constipation scores were statistically better with the abdominal massage during treatment although this was not supported by a change in outcome measures (for example the neurogenic bowel dysfunction score).One small trial in people with spinal cord injury showed statistically significant improvement in total bowel care time using electrical stimulation of abdominal muscles compared with no electrical stimulation (MD 29.3 minutes, 95% CI 7.35 to 51.25).There was evidence from one trial with a low risk of bias that for people with spinal cord injury transanal irrigation, compared against conservative bowel care, statistically improved constipation scores, neurogenic bowel dysfunction score, faecal incontinence score and total time for bowel care (MD 27.4 minutes, 95% CI 7.96 to 46.84). Patients were also more satisfied with this method.Other interventions In one trial in stroke patients, there appeared to be a short term benefit (less than six months) to patients in terms of the number of bowel motions per week with a one-off educational intervention from nurses (a structured nurse assessment leading to targeted education versus routine care), but this did not persist at 12 months. A trial in individuals with spinal cord injury found that a stepwise protocol did not reduce the need for oral laxatives and manual evacuation of stool.Finally, one further trial reported in abstract form showed that oral carbonated water (rather than tap water) improved constipation scores in people who had had a stroke.

Authors' conclusions: There is still remarkably little research on this common and, to patients, very significant issue of bowel management. The available evidence is almost uniformly of low methodological quality. The clinical significance of some of the research findings presented here is difficult to interpret, not least because each intervention has only been addressed in individual trials, against control rather than compared against each other, and the interventions are very different from each other.There was very limited evidence from individual trials in favour of a bulk-forming laxative (psyllium), an isosmotic macrogol laxative, abdominal massage, electrical stimulation and an anticholinesterase-anticholinergic drug combination (neostigmine-glycopyrrolate) compared to no treatment or controls. There was also evidence in favour of transanal irrigation (compared to conservative management), oral carbonated (rather than tap) water and abdominal massage with lifestyle advice (compared to lifestyle advice alone). However, these findings need to be confirmed by larger well-designed controlled trials which should include evaluation of the acceptability of the intervention to patients and the effect on their quality of life.

PubMed Disclaimer

Conflict of interest statement

CN has consulted for Coloplast and Shire

MC has consulted for Coloplast

Figures

1
1
PRISMA study flow diagram.
2
2
Risk of bias graph: review authors' judgements about each risk of bias item presented as percentages across all included studies.
3
3
Risk of bias summary: review authors' judgements about each risk of bias item for each included study.
1.1
1.1. Analysis
Comparison 1 Active treatment versus no treatment or placebo, Outcome 1 Number of bowel motions or successful bowel care routine per week.
1.2
1.2. Analysis
Comparison 1 Active treatment versus no treatment or placebo, Outcome 2 Colonic transit time (hours).
1.3
1.3. Analysis
Comparison 1 Active treatment versus no treatment or placebo, Outcome 3 Stool weight (g).
1.4
1.4. Analysis
Comparison 1 Active treatment versus no treatment or placebo, Outcome 4 Numbers NOT responding to treatment.
1.5
1.5. Analysis
Comparison 1 Active treatment versus no treatment or placebo, Outcome 5 total bowel care time.
2.1
2.1. Analysis
Comparison 2 One treatment versus another treatment, Outcome 1 Number of bowel motions or successful bowel care routines per week.
2.2
2.2. Analysis
Comparison 2 One treatment versus another treatment, Outcome 2 Number of people with no evacuation after stimulation (poor response).
2.3
2.3. Analysis
Comparison 2 One treatment versus another treatment, Outcome 3 Constipation score (various).
2.4
2.4. Analysis
Comparison 2 One treatment versus another treatment, Outcome 4 Neurogenic bowel dysfunction score.
2.5
2.5. Analysis
Comparison 2 One treatment versus another treatment, Outcome 5 Satisfaction with bowel care.
2.6
2.6. Analysis
Comparison 2 One treatment versus another treatment, Outcome 6 Number of people with faecal incontinence.
2.7
2.7. Analysis
Comparison 2 One treatment versus another treatment, Outcome 7 Faecal incontinence score.
2.8
2.8. Analysis
Comparison 2 One treatment versus another treatment, Outcome 8 Total time for bowel care.
2.9
2.9. Analysis
Comparison 2 One treatment versus another treatment, Outcome 9 Number of incontinence episodes between bowel cares, per day or per w.
See this image and copyright information in PMC

Update of

References

References to studies included in this review

Ashraf 1997 {published data only}
    1. Ashraf W, Pfeiffer RF, Park F, Lof J, Quigley EM. Constipation in Parkinson's disease: objective assessment and response to psyllium. Movement Disorders 1997;12(6):946‐51. [MEDLINE: ] - PubMed
Christensen 2006 {published data only}
    1. Christensen P, Andreasen J, Ehlers L. Cost‐effectiveness of a transanal irrigation versus conservative bowel management for spinal cord injury patients (Abstract number 33). Neurourology and Urodynamics 2007;26(5):644‐5. - PubMed
    1. Christensen P, Andreasen J, Ehlers L. Cost‐effectiveness of transanal irrigation versus conservative bowel management for spinal cord injury patients. Spinal Cord 2009;47(2):138‐43. [SRINCONT31669] - PubMed
    1. Christensen P, Bazzocchi G, Coggrave M, Abel R, Hultling C, Krogh K, et al. A randomized, controlled trial of transanal irrigation versus conservative bowel management in spinal cord‐injured patients. Gastroenterology 2006;131(3):738‐47. - PubMed
    1. Christensen P, Bazzocchi G, Coggrave M, Abel R, Hultling C, Krogh K, et al. Treatment of faecal incontinence and constipation in patients with spinal cord injury ‐ a prospective, randomised, controlled, multicentre trial of transanal irrigation vs conservative bowel management (Abstract number 71). Neurourology and Urodynamics 2006; Vol. 25, issue 6:594‐5.
Coggrave 2010 {published data only}
    1. Coggrave M, Norton C, Wilson‐Barnett J. A randomised controlled trial of a progressive protocol for neurogenic bowel management (Abstract number 32). Neurourology and Urodynamics 2007;26(5):643‐4.
    1. Coggrave MJ, Norton C. The need for manual evacuation and oral laxatives in the management of neurogenic bowel dysfunction after spinal cord injury: a randomised trial. Spinal Cord 2010;48:504‐10. - PubMed
Cornell 1973 {published data only}
    1. Cornell SA, Campion L, Bacero S, Frazier J, Kjellstrom M, Purdy S. Comparison of three bowel management programs during rehabilitation of spinal cord injured patients. Nursing Research 1973;22(4):321‐8. [MEDLINE: ] - PubMed
Dahl 2005 {published data only}
    1. Dahl WJ, Whiting SJ, Isaac TM, Weeks SJ, Arnold CJ. Effects of thickened beverages fortified with inulin on beverage acceptance, gastrointestinal function, and bone resorption in institutionalized adults. Nutrition 2005;21(3):308‐11. - PubMed
Emly 1998 {published data only}
    1. Emly M, Cooper S, Vail A. Colonic motility in profoundly disabled people: a comparison of massage and laxative therapy in the management of constipation. Physiotherapy 1998;84(4):178‐83.
Harari 2004 {published data only}
    1. Harari D, Norton C, Lockwood L, Swift C. Treatment of constipation and faecal incontinence in stroke patients: randomized controlled trial. Stroke 2004;35(11):2549‐55. - PubMed
House 1997 {published data only}
    1. House JG, Stiens SA. Pharmacologically initiated defecation for persons with spinal cord injury: effectiveness of three agents. Archives of Physical Medicine and Rehabilitation 1997;78(10):1062‐5. [MEDLINE: ] - PubMed
Huang 2002 {published data only}
    1. Huang XB, Li ZX. Clinical observation on effect of qirong runchang oral liquid in treating constipation after stroke. Zhongguo Zhong Xi Yi Jie He Za Zhi Zhongguo Zhonxiyi Jehe Zazhi 2002;22(8):622‐3. - PubMed
Jeon 2005 {published data only}
    1. Jeon SY, Jung HM. [The effects of abdominal meridian massage on constipation among CVA patients]. [Korean]. Daehan Ganho Haghoeji 2005;35(1):135‐42. - PubMed
Korsten 2004 {published data only}
    1. Korsten MA, Fajardo NR, Rosman AS, Creasey GH, Spungen AM, Bauman WA. Difficulty with evacuation after spinal cord injury: Colonic motility during sleep and effects of abdominal wall stimulation. Journal of Rehabilitation Research and Development 2004;41(1):95‐9. - PubMed
Korsten 2005 {published data only}
    1. Korsten MA, Rosman AS, Ng A, Cavusoglu E, Spungen AM, Radulovic M, et al. Infusion of neostigmine‐glycopyrrolate for bowel evacuation in persons with spinal cord injury. American Journal of Gastroenterology 2005;100(7):1560‐5. - PubMed
Krogh 2002 {published data only}
    1. Krogh K, Jensen MB, Gandrup P, Laurberg S, Nilsson J, Kerstens R, et al. Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury. Scandinavian Journal of Gastroenterology 2002;37(4):431‐6. - PubMed
McClurg 2011 {published data only}
    1. McClurg D, Hagen S, Hawkins S, Lowe‐Strong A. Abdominal massage for the alleviation of constipation in people with multiple sclerosis: a randomised controlled feasibility study (Abstract number 117). Neurourology and Urodynamics 2010;29(6):975‐6.
    1. McClurg D, Hagen S, Hawkins S, Lowe‐Strong A. Abdominal massage for the alleviation of constipation symptoms in people with multiple sclerosis: a randomized controlled feasibility study. Multiple Sclerosis 2011;17(2):223‐33. [PUBMED: 20940182] - PubMed
Medaer 1999 {published data only}
    1. Medaer R, D'Hooghe B, Guillaume D, Truyen L, Kerstens R, Pauw M, et al. Efficacy and tolerability of procalopride in patients with constipation due to multiple sclerosis: A double‐blind, placebo‐controlled pilot study [Abstract number P0253]. Gut 1999;45 Suppl V:A137.
Mun 2011 {published data only}
    1. Mun JH, Jun SS. [Effects of carbonated water intake on constipation in elderly patients following a cerebrovascular accident]. [Korean]. Journal of Korean Academy of Nursing 2011;41(2):269‐75. - PubMed
Rosman 2008 {published data only}
    1. Rosman AS, Chaparala G, Monga A, Spungen AM, Bauman WA, Korsten MA. Intramuscular neostimine and glycopyrrolate safely accelerated bowel evacuation in patients with spinal cord injury and defecation disorders. Digestive Diseases and Sciences 2008;53:2710‐3. - PubMed
Venn 1992 {published data only}
    1. Venn MR, Taft L, Carpentier B, Applebaugh G. The influence of timing and suppository use on efficiency and effectiveness of bowel training after a stroke. Rehabilitation Nursing 1992;17(3):116‐20. [MEDLINE: ] - PubMed
Wang 2008 {published data only}
    1. Wang DS, Wang S, Kong LL, Wang WY, Cui XM. [Clinical observation on abdominal electroacupuncture for treatment of poststroke constipation]. [Chinese]. Zhongguo Zhenjiu 2008;28(1):7‐9. - PubMed
Zangaglia 2007 {published data only}
    1. Zangaglia R, Martignoni E, Glorioso M, Ossola M, Riboldazzi G, Calandrella D, et al. Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo‐controlled study. Movement Disorders 2007;22(9):1239‐44. - PubMed

References to studies excluded from this review

Amir 1998 {published data only}
    1. Amir I, Sharma R, Bauman WA, Korsten MA. Bowel care for individuals with spinal cord injury: comparison of four approaches. Journal of Spinal Cord Medicine 1998;21(1):21‐4. [MEDLINE: ] - PubMed
Badiali 1991 {published data only}
    1. Badiali D, Corazziari E, Habib FI, Bausano G, Viscardi M, Anzini F, et al. A double‐blind controlled trial on the effect of cisapride in the treatment of constipation in paraplegic patients. Journal of Gastrointestinal Motility 1991;3(4):263‐7.
Badiali 1997 {published data only}
    1. Badiali D, Bracci F, Castellano V, Corazziari E, Fuoco U, Habib FI, et al. Sequential treatment of chronic constipation in paraplegic subjects. Spinal Cord 1997;35(2):116‐20. [MEDLINE: ] - PubMed
Barnes 1985 {published data only}
    1. Barnes MP, Bates D, Cartlidge NE, French JM, Shaw DA. Hyperbaric oxygen and multiple sclerosis: short‐term results of a placebo‐controlled, double‐blind trial. Lancet 1985;1(8424):297‐300. [MEDLINE: ] - PubMed
Binnie 1988 {published data only}
    1. Binnie NR, Creasey GH, Edmond P, Smith AN. The action of cisapride on the chronic constipation of paraplegia. Paraplegia 1988;26(3):151‐8. [MEDLINE: ] - PubMed
Binnie 1991 {published data only}
    1. Binnie NR, Smith AN, Creasey GH, Edmond P. Constipation associated with chronic spinal cord injury: the effect of pelvic parasympathetic stimulation by the Brindley stimulator. Paraplegia 1991;29(7):463‐9. [MEDLINE: ] - PubMed
Bliss 2011 {published data only}
    1. Bliss DZ, Savik K, Jung HJ, Whitebird R, Lowry A. Symptoms associated with dietary fiber supplementation over time in individuals with fecal incontinence. Nursing Research 2011;60(3 Suppl):S58‐S67. - PMC - PubMed
Bond 2005 {published data only}
    1. Bond C. The anal plug: an evaluation of a novel management option for faecal incontinence. Final report to Chief Scientist Office, Scottish Executive Health Department, Edinburgh 2005.
Carter 1988 {published data only}
    1. Carter LT, Oliveira DO, Duponte J, Lynch S. The relationship of cognitive skills performance to activities of daily living in stroke patients. American Journal of Occupational Therapy 1988;42(7):449‐55. - PubMed
Chapman 1974 {published data only}
    1. Chapman DH, Pittelli JJ. Double‐blind comparison of alophen with its components for cathartic effects. Current Therapeutic Research, Clinical and Experimental 1974;16(8):817‐20. [MEDLINE: ] - PubMed
de Both 1992 {published data only}
    1. Both PSM, Groot GH, Slootman HR. Effects of cisapride on constipation in paraplegic patients: a placebo‐controlled randomized double‐blind cross‐over study. European Journal of Gastroenterology & Hepatology 1992;4:1013‐7.
Dunn 1994 {published data only}
    1. Dunn KL, Galka ML. A comparison of the effectiveness of Therevac SB and bisacodyl suppositories in SCI patients' bowel programs. Rehabilitation Nursing 1994;19(6):334‐8. [MEDLINE: ] - PubMed
Fang 2003 {published data only}
    1. Fang Y, Chen X, Li H, Lin J, Huang R, Zeng J. A study on additional early physiotherapy after stroke and factors affecting functional recovery. Clinical Rehabilitation 2003;17(6):608‐17. - PubMed
Frisbie 1997 {published data only}
    1. Frisbie JH. Improved bowel care with a polyethylene glycol based bisacodyl suppository. Journal of Spinal Cord Medicine 1997;20(2):227‐9. [MEDLINE: ] - PubMed
Frost 1993 {published data only}
    1. Frost F, Hartwig D, Jaeger R, Leffler E, Wu Y. Electrical stimulation of the sacral dermatomes in spinal cord injury: effect on rectal manometry and bowel emptying. Archives of Physical Medicine and Rehabilitation 1993;74(7):696‐701. [MEDLINE: ] - PubMed
Geders 1995 {published data only}
    1. Geders JM, Gaing A, Bauman WA, Korsten MA. The effect of cisapride on segmental colonic transit time in patients with spinal cord injury. American Journal of Gastroenterology 1995;90(2):285‐9. [MEDLINE: ] - PubMed
Heymen 2005 {published data only}
    1. Heymen S, Scarlett Y, Jones K, Drossman D, Ringel Y, Whitehead WE. Randomized controlled trial shows biofeedback to be superior to alternative treatments for patients with pelvic floor dyssenergia‐type constipation (Abstract number S1838). Gastroenterology 2005;128 Suppl 2:A266. - PubMed
Kim 1991 {published data only}
    1. Kim BE, Rhee HY. [A study of the effects of health contracts on the performance level for activities of daily living in the hemiplegic patients]. [Korean]. Kanho Hakhoe Chi [Journal of Nurses Academic Society] 1991;21(1):63‐78. [MEDLINE: ] - PubMed
Latimer 1984 {published data only}
    1. Latimer PR, Campbell D, Kasperski J. A components analysis of biofeedback in the treatment of fecal incontinence. Biofeedback and Self‐Regulation 1984;9(3):311‐24. [MEDLINE: ] - PubMed
Loening‐Baucke 1988 {published data only}
    1. Loening‐Baucke V, Desch L, Wolraich M. Biofeedback training for patients with myelomeningocele and fecal incontinence. Developmental Medicine and Child Neurology 1988;30(6):781‐90. [MEDLINE: ] - PubMed
Markwell 2006 {published data only}
    1. Markwell S, Unkles E, Hitchman K, Lincoln D, Chumbley J, Theile G, et al. A randomised controlled clinical trial to evaluate the efficacy of specific muscle rehabilitation in people with faecal incontinence (report amended June 2007). Canberra, Australia: Department of Health and Ageing, Australian Government, 2006.
Marshall 1997 {published data only}
    1. Marshall DF, Boston VE. Altered bladder and bowel function following cutaneous electrical field stimulation in children with spina bifida‐‐interim results of a randomized double‐blind placebo‐controlled trial. European Journal of Pediatric Surgery 1997;7 Suppl 1:41‐3. [MEDLINE: ] - PubMed
Munchiando 1993 {published data only}
    1. Munchiando JF, Kendall K. Comparison of the effectiveness of two bowel programs for CVA patients. Rehabilitation Nursing 1993;18(3):168‐72. [MEDLINE: ] - PubMed
Petajan 1996 {published data only}
    1. Petajan JH, Gappmaier E, White AT, Spencer MK, Mino L, Hicks RW. Impact of aerobic training on fitness and quality of life in multiple sclerosis. Annals of Neurology 1996;39(4):432‐41. [MEDLINE: ] - PubMed
Rajendran 1992 {published data only}
    1. Rajendran SK, Reiser JR, Bauman W, Zhang RL, Gordon SK, Korsten MA. Gastrointestinal transit after spinal cord injury: effect of cisapride. American Journal of Gastroenterology 1992;87(11):1614‐7. - PubMed
Rao 2005 {published data only}
    1. Rao SS, Kinkade KJ, Schulze KS, Nygaard II, Brown K, Stumbo PI, et al. Biofeedback therapy (bt) for dyssynergic constipation ‐ randomized controlled trial (Abstract number S1851). Gastroenterology 2005;128 Suppl 2:A269.
Rao 2010 {published data only}
    1. Rao SS, Valestin J, Brown CK, Zimmerman B, Schulze K. Long‐term efficacy of biofeedback therapy for dyssynergic defecation: randomized controlled trial. American Journal of Gastroenterology 2010;105(4):890‐6. - PMC - PubMed
Stiens 1995 {published data only}
    1. Stiens SA. Reduction in bowel program duration with polyethylene glycol based bisacodyl suppositories. Archives of Physical Medicine and Rehabilitation 1995;76(7):674‐7. [MEDLINE: ] - PubMed
Stiens 1998 {published data only}
    1. Stiens SA, Luttrel W, Binard JE. Polyethylene glycol versus vegetable oil based bisacodyl suppositories to initiate side‐lying bowel care: a clinical trial in persons with spinal cord injury. Spinal Cord 1998;36(11):777‐81. [MEDLINE: ] - PubMed
Sullivan 2006 {published data only}
    1. Sullivan KL, Staffetti JF, Hauser RA, Dunne PB, Zesiewicz TA. Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease. Movement Disorders 2006;21(1):115‐6. - PubMed
Tekeoglu 1998 {published data only}
    1. Tekeoglu Y, Adak B, Goksoy T. Effect of transcutaneous electrical nerve stimulation (TENS) on Barthel Activities of Daily Living (ADL) index score following stroke. Clinical Rehabilitation 1998;12(4):277‐80. - PubMed
Van Winckel 2005 {published data only}
    1. Winckel M. Clinical evaluation of a new anal medical device to achieve faecal continence in spina bifida and anal atresia patients. [plug manufacturer] 2005.
Weinland 2010 {published data only}
    1. Weinland SR, Morris CB, Dalton C, Hu Y, Whitehead WE, Toner BB, et al. Cognitive factors affect treatment response to medical and psychological treatments in functional bowel disorders. American Journal of Gastroenterology 2010;105(6):1397‐406. - PubMed

Additional references

Aaronson 1985
    1. Aaronson MJ, Freed MM, Burakoff R. Colonic myoelectric activity in persons with spinal cord injury. Digestive Diseases and Sciences 1985;30(4):295‐300. - PubMed
Barnes 1987
    1. Barnes MP, Bates D, Cartlidge NE, French JM, Shaw DA. Hyperbaric oxygen and multiple sclerosis: final results of a placebo‐controlled, double‐blind trial. Journal of Neurology, Neurosurgery, and Psychiatry 1987;50(11):1402‐6. [MEDLINE: ] - PMC - PubMed
Branagan 2003
    1. Branagan G, Tromans A, Finnis D. Effect of stoma formation on bowel care and quality of life in patients with spinal cord injury. Spinal Cord 2003;41:680‐3. - PubMed
Brocklehurst 1985
    1. Brocklehurst JC, Andrews K, Richards B, Laycock PJ. Incidence and correlates of incontinence in stroke patients. Journal of the American Geriatrics Society 1985;33(8):540‐2. [MEDLINE: ] - PubMed
Byrne 2002
    1. Byrne CM, Pager CK, Rex J, Roberts R, Solomon MJ. Assessment of quality of life in the treatment of patients with neuropathic fecal incontinence. Diseases of the Colon and Rectum 2002;45(11):1431‐6. [PUBMED: 12432287] - PubMed
Cameron 1996
    1. Cameron KJ, Nyulasi IB, Collier GR, Brown DJ. Assessment of the effect of increased dietary fibre intake on bowel function in patients with spinal cord injury. Spinal Cord 1996;34(5):277‐83. [MEDLINE: ] - PubMed
Camilleri 2008
    1. Camilleri M, Kerstens R, Rykx A, Vandeplassche L. A placebo‐controlled trial of prucalopride for severe chronic constipation.[see comment]. New England Journal of Medicine 2008;358(22):2344‐54. - PubMed
Cheskin 1995
    1. Cheskin LJ, Kamal N, Crowell MD, Schuster MM, Whitehead WE. Mechanisms of constipation in older persons and effects of fiber compared with placebo. Journal of American Geriatric Society 1995;43(6):666‐9. - PubMed
Chia 1995
    1. Chia YW, Fowler CJ, Kamm MA, Henry MM, Lemieux MC, et al. Prevalence of bowel dysfunction in patients with multiple sclerosis and bladder dysfunction. Journal of Neurology 1995;242(2):105‐8. [MEDLINE: ] - PubMed
Chia 1996
    1. Chia YW, Lee TK, Kour NW, Tung KH, Tan ES. Microchip implants on the anterior sacral roots in patients with spinal trauma: does it improve bowel function?. Diseases of the Colon and Rectum 1996;39(6):690‐4. [MEDLINE: ] - PubMed
Christensen 2009
    1. Christensen P, Andreasen J, Ehlers L. Cost‐effectiveness of transanal irrigation versus conservative bowel management for spinal cord injury patients. Spinal Cord 2009;47(2):138‐43. - PubMed
Coggrave 2009
    1. Coggrave M, Norton C, Wilson‐Barnett J. Management of neurogenic bowel dysfunction in the community after spinal cord injury: a postal survey in the United Kingdom. Spinal Cord 2009;47(4):323‐30. - PubMed
Coggrave 2012a
    1. Coggrave MJ, Ingram RM, Gardner BP, Norton CS. The impact of stoma for bowel management after spinal cord injury. Spinal Cord 2012;50(11):848‐52. - PubMed
Coggrave 2012b
    1. Coggrave M, Ash D, Adcock C, Brown A, Davies D, Dehal‐Clark A, et al. Guidelines for management of neurogenic bowel dysfunction in individuals with central neurological conditions. Multidisciplinary Association of Spinal Cord Injured Professionals (MASCIP). Available from: http://www.mascip.co.uk/guidelines.aspx, 2012.
Coremans 2003
    1. Coremans G, Kerstens R, De Pauw, Stevens M. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double‐blind placebo clinical trial. Digestion 2003;67(1‐2):82‐9. - PubMed
Correa 2000
    1. Correa GI, Rotter KP. Clinical evaluation and management of neurogenic bowel after spinal cord injury. Spinal Cord 2000;38(5):301‐8. - PubMed
Creasey 2001
    1. Creasey GH, Grill JH, Korsten M, U HS, Betz R, Anderson R, et al. An implantable neuroprosthesis for restoring bladder and bowel control to patients with spinal cord injuries: a mulitcenter trial. Archives of Physical Medicine and Rehabilitation 2001;82(11):1512‐9. - PubMed
Davies 1998
    1. Davies GJ, Dettmar PW, Hoare RC. The influence of ispaghula husk on bowel habit. Journal of Royal Society of Health 1998;118(5):267‐71. - PubMed
De Looze 1998
    1. Looze D, Laere M, Muynck M, Beke R, Elewaut A. Constipation and other chronic gastrointestinal problems in spinal cord injury patients. Spinal Cord 1998;36(1):63‐6. - PubMed
Dettmar 1998
    1. Dettmar PW, Sykes J. A multi‐centre, general practice comparison of ispaghula husk with lactose and other laxatives in the treatment of simple constipation. Current Medical Research and Opinion 1998;14(4):227‐33. - PubMed
Dey 2003
    1. Dey R, Ferguson C, Kenny SE, Shanker KR, Coldicutt P, Bailee CT, et al. After the honeymoon‐‐medium‐term outcome of antegrade continence enema procedure. Journal of Pediatric Surgery 2003;38(1):65‐8. - PubMed
Driver 1998
    1. Driver C, Barrow C, Fishwick J, Gough D, Bianchi A, Dickson A. The Malone antegrade colonic enema procedure: outcome and lessons of 6 years' experience. Pediatric Surgery International 1998;13(5‐6):370‐2. - PubMed
Emmanuel 2002
    1. Emmanuel AV, Roy AJ, Nicholls TJ, Kamm MA. Prucalopride, a systemic enterokinetic, for the treatment of constipation. Alimentary Pharmacology & Therapeutics 2002;16(7):1347‐56. - PubMed
Emmanuel 2010
    1. Emmanuel A. Review of the efficacy and safety of transanal irrigation for neurogenic bowel dysfunction. Spinal Cord 2010;48(9):664‐73. - PubMed
Faaborg 2010
    1. Faaborg PM, Christensen P, Buntzen S, Laurberg S, Krogh K. Anorectal function after long‐term transanal colonic irrigation. Colorectal Disease 2010;12(10 Online):e314‐9. - PubMed
Ferriman 2002
    1. Ferriman A. UK License for cisapride suspended. BMJ 2002;321:259. - PMC - PubMed
Gattuso 1994
    1. Gattuso JM, Kamm MA. Adverse effects of drugs used in the management of constipation and diarrhoea. Drug Safety 1994;10(1):47‐65. - PubMed
Glickman 1996
    1. Glickman S, Kamm MA. Bowel dysfunction in spinal cord injury patients. Lancet 1996;347(9016):1651‐3. [MEDLINE: ] - PubMed
Gstaltner 2008
    1. Gstaltner K, Rosen H, Hufgard J, Mark R, Schrei K. Sacral nerve stimulation as an option for the treatment of faecal incontinence in patients suffering from cauda equina syndrome. Spinal Cord 2008;46(9):644‐7. - PubMed
Han 1998
    1. Han TR, Kim JH, Kwon BS. Chronic gastrointestinal problems and bowel dysfunction in patients with spinal cord injury. Spinal Cord 1998;36(7):485‐90. - PubMed
Harari 1997
    1. Harari D, Sarkarati M, Gurwitz J, McGlinchey‐Berroth G, Minaker K. Constipation‐related symptoms and bowel program concerning individuals with spinal cord injury. Spinal Cord 1997;35:394‐401. - PubMed
Harari 2003
    1. Harari D, Coshall C, Udd AG, Olfe CD. New‐onset fecal incontinence after stroke: prevalence, natural history, risk factors, and impact. Stroke 2003;34(1):144‐50. - PubMed
Hinds 1990
    1. Hinds JP, Eidelman BH, Wald A. Prevalence of bowel dysfunction in multiple sclerosis. A population survey. Gastroenterology 1990;98(6):1538‐42. [MEDLINE: ] - PubMed
Jarrett 2005
    1. Jarrett ME, Matzel KE, Christiansen J, Rosen H, Bittorf B, Stosser M, et al. Sacral nerve stimulation for faecal incontinence in patients with previous partial spinal injury including disc prolapse. British Journal of Surgery 2005;92(6):734‐9. - PubMed
Kachourbos 2000
    1. Kachourbos MJ, Creasey GH. Health promotion in motion: improving quality of life for persons with neurogenic bladder and bowel using assistive technology [corrected] [published erratum appears in SCI Nursing 2000 Winter;17(4):221]. SCI Nursing 2000;17(3):125‐9. [PUBMED: 12037826] - PubMed
Kavchak‐Keyes 2000
    1. Kavchak‐Keyes MA. Autonomic hyperreflexia. Rehabilitation Nursing 2000;25(1):31‐5. - PubMed
Krassioukov 2010
    1. Krassioukov A, Eng JJ, Claxton G, Sakakibara BM, Shum S. Neurogenic bowel management after spinal cord injury: a systematic review of the evidence. Spinal Cord 2010;48(10):718‐33. - PMC - PubMed
Krogh 1997
    1. Krogh K, Nielsen J, Djurhuus JC, Mosdal C, Sabroe S, Laurberg S. Colorectal function in patients with spinal cord lesions. Diseases of the Colon and Rectum 1997;40(10):1233‐9. [MEDLINE: ] - PubMed
Liu 2005
    1. Liu LQ, Chung EAL, Coggrave M, Bycroft J, Norton C, Emmanuel AV, et al. Sacral Anterior Root Stimulator Implants (SARSI): Their effect on patterns of bowel management in patients with spinal cord injury (Abstract number 48/5). Proceedings of the 44th Annual Scientific Meeting of the International Spinal Cord Society (ISCoS), 2005 Oct 4 to 8, Munich and Murnau, Germany 2005.
Lombardi 2010
    1. Lombardi G, Popolo G, Cecconi F, Surrenti E, Macchiarella A. Clinical outcome of sacral neuromodulation in incomplete spinal cord‐injured patients suffering from neurogenic bowel dysfunctions. Spinal Cord 2010;48(2):154‐9. - PubMed
Longstreth 2006
    1. Longstreth GF, Thompson WD, Chey WG, Houghton LA, Mearin F, Spiller RC. Functional bowel disorders. Gastroenterology 2006;130(5):1480‐91. - PubMed
Lynch 2001
    1. Lynch AC, Dobbs BR, Keating J, Frizelle FA. The prevalence of faecal incontinence and constipation in a general New Zealand population; a postal survey. New Zealand Medical Journal 2001;114(1142):474‐7. - PubMed
MacDonagh 1990
    1. MacDonagh RP, Sun WM, Smallwood R, Forster D, Read NW. Control of defecation in patients with spinal injuries by stimulation of sacral anterior nerve roots. BMJ 1990;300(6738):1494‐7. [MEDLINE: ] - PMC - PubMed
Mahoney 1965
    1. Mahoney F, Barthel D. Functional evaluation: the Barthel Index. Maryland Medical Journal 1965;14:61‐5. - PubMed
Malone 1994
    1. Malone P, Wheeler R, Williams J. Continence in patients with spina bifida: long term results. Archives of Diseases in Children 1997;70(2):107‐10. - PMC - PubMed
McDonnell 2000
    1. McDonnell G, McCann J. Issues of medical management in adults with spinal bifida. Child's Nervous System 2000;16(4):222‐7. - PubMed
McRorie 1998
    1. McRorie JW, Daggy BP, Morel JG, Diersing PS, Miner PB, Robinson M. Psyllium is superior to docusate sodium for treatment of chronic constipation. Alimentary Pharmacology & Therapeutics 1998;12(5):491‐7. - PubMed
Menardo 1987
    1. Menardo G, Bausano G, Corazziari E, Fazio A, Marangi A, Genta V. Large‐bowel transit in paraplegic patients. Diseases of the Colon and Rectum 1987;30(12):294‐8. - PubMed
Menter 1997
    1. Menter R, Weitzenkamp D, Cooper D, Bingley J, Charlifue S, Whiteneck G. Bowel management outcomes in individuals with long‐term spinal cord injuries. Spinal Cord 1997;35(9):608‐12. [MEDLINE: ] - PubMed
Nakayama 1997
    1. Nakayama H, Jorgensen HS, Pedersen PM, Raaschou HO, Olsen TS. Prevalence and risk factors of incontinence after stroke. The Copenhagen Stroke Study. Stroke 1997;28(1):58‐62. [MEDLINE: ] - PubMed
Norton 2001
    1. Norton C, Chelvanayagam S. Methodology of biofeedback for adults with fecal incontinence: a program of care. Journal of Wound, Ostomy, and Continence Nursing 2001;28(3):156‐68. - PubMed
Paris 2011
    1. Paris G, Gourcerol G, Leroi AM. Management of neurogenic bowel dysfunction. European Journal of Physical and Rehabilitation Medicine. 2011;47(4):661‐76. - PubMed
Quigley 1996
    1. Quigley EM. Gastrointestinal dysfunction in Parkinson's disease. Seminars in Neurology 1996;16(3):245‐50. [MEDLINE: ] - PubMed
Quigley 2009
    1. Quigley EM, Vandeplassche L, Kerstens R, Ausma J. Clinical trial: the efficacy, impact on quality of life, and safety and tolerability of prucalopride in severe chronic constipation‐‐a 12‐week, randomized, double‐blind, placebo‐controlled study. Alimentary Pharmacology & Therapeutics 2009;29(3):315‐28. - PubMed
Sakikibara 2010
    1. Sakikibara R, Fowler C, Takamichi H. Parkinson's disease. Chapter 12. In: Fowler C, Panicker J, Emmanuel A editor(s). Pelvic Organ Dysfunction in Neurological Disease: Clinical Management and Rehabilitation. Cambridge, UK: Cambridge University Press, 2010:187‐205.
Sloots 2002
    1. Sloots CE, Poen AC, Kerstens R, Stevens M, Pauw M, Oene JC, et al. Effects of prucalopride on colonic transit, anorectal function and bowel habits in patients with chronic constipation. Alimentary Pharmacology & Therapeutics 2002;16(4):759‐67. - PubMed
Sonnenberg 1994
    1. Sonnenberg A, Tsou VT, Muller AD. The "institutional colon": a frequent colonic dysmotility in psychiatric and neurologic disease. American Journal of Gastroenterology 1994;89(1):62‐6. - PubMed
Stiens 1997
    1. Stiens SA, Bergman SB, Goetz LL. Neurogenic bowel dysfunction after spinal cord injury: clinical evaluation and rehabilitative management. Archives of Physical Medicine and Rehabilitation 1997;78:S86–S102. [MEDLINE: ] - PubMed
Stocchi 2000
    1. Stocchi F, Baddiali D, Vacca L, D'Alba L, Bracci F, Ruggieri S, et al. Anorectal function in multiple system atrophy and Parkinson's disease. Movement Disorders 2000;15(1):71‐6. - PubMed
Suehiro 2005
    1. Suehiro T, Matsuma T, Shikada Y, Sugimachi K. The effect of the herbal medicines dai‐kenchi‐to and keisha‐bukuryo‐gan on bowel movement after colorectal surgery. Hepatogastroenterology 2005;52(61):97‐100. - PubMed
Tack 2009
    1. Tack J, Outryve M, Beyens G, Kerstens R, Vandeplassche L. Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives. Gut 2009;58(3):357‐65. - PubMed
Turk 1997
    1. Turk M, Scandale J, Rosenbaum P. The health of women with cerebral palsy. Physical Medicine and Rehabilitation Clinics of North America 1997;12(1):158‐68. - PubMed
Valles 2009
    1. Valles M, Rodriguez A, Borau A, Mearin F. Effect of sacral anterior root stimulator on bowel dysfunction in patients with spinal cord injury. Diseases.of the.Colon and Rectum 2009;52(5):986‐92. - PubMed
Varma 1986
    1. Varma JS, Binnie N, Smith AN, Creasey GH, Edmond P. Differential effects of sacral anterior root stimulation on anal sphincter and colorectal motility in spinally injured man. British Journal of Surgery 1986;73(6):478‐82. [MEDLINE: ] - PubMed
Verhoef 2005
    1. Verhoef M, Lurvink M, Barf HA, Post MWM, Asbeck FW, Gooskens RHJM, et al. High prevalence of incontinence among young adults with spinal bifida: description, prediction and problem perception. Spinal Cord 2005;43:331‐40. - PubMed
Ware 1993
    1. Ware JE. Measuring patients' views: the optimum outcome measure. SF36: a valid, reliable assessment of health from the patient's point of view. BMJ 1993;306(6890):1429‐30. - PMC - PubMed
Whitehead 1999
    1. Whitehead WE, Wald A, Diamant NE, Enck P, Pemberton JH, Rao SS. Functional disorders of the anus and rectum. Gut 1999;45 Suppl 2:1155‐9. [MEDLINE: ] - PMC - PubMed
Wiesel 2000
    1. Wiesel PH, Norton C, Roy AJ, Storrie JB, Bowers J, Kamm MA. Gut focused behavioural treatment (biofeedback) for constipation and faecal incontinence in multiple sclerosis. Journal of Neurology, Neurosurgery, and Psychiatry 2000;69(2):240‐3. - PMC - PubMed
Zigmond 1983
    1. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatrica Scandinavica 1983;67(6):361‐70. - PubMed

References to other published versions of this review

Coggrave 2006
    1. Coggrave M, Wiesel P, Norton CC. Management of faecal incontinence and constipation in adults with central neurological diseases. Cochrane Database of Systematic Reviews 2006, Issue 2. [DOI: 10.1002/14651858.CD002115.pub3] - DOI - PubMed

Publication types

MeSH terms